The total issue size of Alkosign IPO is up to ₹11.53 Cr whereas the issue size of the Fabino Life Sciences IPO is up to ₹3.07 Cr. The final issue price of Alkosign IPO is ₹45.00 per share and of Fabino Life Sciences IPO is ₹36.00 per share.
Alkosign IPO opens on Jan 18, 2022, while Fabino Life Sciences IPO opens on Dec 31, 2021. The closing date of Alkosign IPO and Fabino Life Sciences IPO is Jan 21, 2022, and Jan 05, 2022, respectively.
In the Alkosign IPO Retail Individual Investors (RII) are offered 12,81,000 shares while in Fabino Life Sciences IPO retail investors are offered 12,81,000 shares. Qualified Institutional Buyers (QIB) are offered in Alkosign IPO and in Fabino Life Sciences IPO.